• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING STENT SYSTEM Back to Search Results
Catalog Number S-45-100-120-P6
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Occlusion (1984); Pain (1994)
Event Date 11/13/2014
Event Type  Injury  
Event Description
Subsequent to the initial medwatch, additional information received reported that the patient was critically ischemic.No additional information was provided.
 
Manufacturer Narrative
(b)(4).There was no reported device malfunction, and the product was not returned.The job traveler for the reported lot revealed no nonconforming reports.The reported patient effects of ischemia, occlusion, pain, and surgery are listed in the supera peripheral stent system, instructions for use (ifu).Although a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined, there is no indication of a product quality deficiency with respect to manufacturing, design or labeling.
 
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The stent remains in the patient.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.The other supera referenced is being filed under a separate medwatch mfr number.
 
Event Description
It was reported that the procedure was to treat a superficial femoral artery (sfa) and a popliteal artery performed on (b)(6) 2014.The sfa was treated with a 5.5 x 60 mm supera stent and the popliteal was treated with a 4.5 x 100 mm supera stent.There were no issues during the procedure.On (b)(6) 2014, the patient presented with pain in the leg and no blood flow and on (b)(6) 2014 femoropopliteal bypass surgery was performed.Angiography was not performed to see if there was thrombosis or restenosis in the supera stents.It is unknown at this time why bypass was performed.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA SELF-EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 462
Manufacturer (Section G)
WEBSTER, TX USA REG#3005325609
abbott vascular
26531 ynez rd.
temecula CA 92591 462
Manufacturer Contact
connie speck
abbott vascular
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key4333721
MDR Text Key5431879
Report Number2024168-2014-08195
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial,Followup
Report Date 11/21/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/16/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/30/2015
Device Catalogue NumberS-45-100-120-P6
Device Lot Number02217054
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/05/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/01/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Disability;
Patient Age61 YR
-
-